Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease.
about
Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III studyGenomic variants, genes, and pathways of Alzheimer's disease: An overview.Atrophy rates accelerate in amnestic mild cognitive impairment.Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memoryPlasma beta-amyloid and duration of Alzheimer's disease in adults with Down syndrome.Clinical rationale of genetic testing in dementiaBrain atrophy in frontotemporal dementia.Survival in Alzheimer disease: a multiethnic, population-based study of incident casesApolipoprotein E: from lipid transport to neurobiologyThe role of apolipoprotein E in Alzheimer's disease.Decline in verbal memory during preclinical Alzheimer's disease: examination of the effect of APOE genotypeInteraction between vascular factors and the APOE ε4 allele in predicting rate of progression in Alzheimer's diseaseApolipoprotein E and Alzheimer disease: genotype-specific risks by age and sexEpidemiology of the dementias: recent developments and new approaches.Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's diseaseAPOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer diseaseMapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivoLongitudinal MRI findings from the vitamin E and donepezil treatment study for MCI.The influence of ApoE4 on clinical progression of dementia: a meta-analysis.Rapid cognitive decline in Alzheimer's disease: a literature review.Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.Apolipoprotein E genotype and gender influence response to tacrine therapy.Diagnostic usefulness of apolipoprotein E epsilon 4 in the diagnosis of the dementias.d-penicillamine reduces serum oxidative stress in Alzheimer's disease patients.Disrupted Brain Structural Connectivity: Pathological Interactions Between Genetic APOE ε4 Status and Developed MCI Condition.Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.Cognitive impairment in Alzheimer's disease is modified by APOE genotype.Lack of association between the apolipoprotein E genotype and depression in Alzheimer's disease.Pattern and progression of cognitive decline in Alzheimer's disease: role of premorbid intelligence and ApoE genotype.Apolipoprotein E epsilon 4 allele in association with global cognitive performance and CSF markers in Alzheimer's disease.NIA/AIzA Conference on apolipoprotein E genotyping in Alzheimer's disease. Bibliography.The current status of apo E4 as a risk factor for Alzheimer's disease: an epidemiological perspective.The use of apolipoprotein E genotyping as a diagnostic test in suspected Alzheimer's disease.Apolipoprotein E epsilon4 allele increases risk for psychotic symptoms in Alzheimer's disease.
P2860
Q24628969-93D9B1FB-A7A7-458D-84CC-1C3003A0CF55Q30240093-6E57EDC6-C370-4459-B33A-7DC35D7AE268Q30489846-6EC7EC73-E2BC-487A-A243-D3DBA2D249A5Q30513966-1C336B6B-F41A-4750-94A5-C2F51EF5D71AQ33609644-EB9D78A9-C3D6-4158-A1C6-64810E9039F4Q33714955-59ACC25E-BD99-412B-ADA3-517BF6730AD1Q33735444-12B8F1A2-406B-4647-A96F-5631A75E33A0Q33745430-DE1DF187-2F16-4543-BB51-265C736EB10CQ34497951-918495DB-B429-447E-81ED-5CB0DDF7F3B0Q34603092-FC10241B-2713-48BA-9986-C5610E4D7D20Q35107333-C13CD420-4067-4C44-9B44-86A5CC4D6B94Q35189449-5244D253-DDD9-41D3-A28F-1FF800BBB7EBQ35238425-F0AC4324-6C49-437C-9A7E-9C3BA4758A42Q36891191-00CCDF59-92D7-45C5-90B3-4CEAB58A1E2DQ36899824-72805FE8-0EF7-46F1-AB65-1A26E8DA2580Q37178272-C38119B6-F1E3-4670-AB51-D4B250F36EFFQ37337930-518C25B1-1441-48C1-AEBB-A97147FAAF91Q37402321-5559116D-98E6-4FC4-9066-01D7462B1206Q37789233-B2526579-A8FE-4C49-A78C-3125A8A2F4E7Q38178371-AC0BC946-9E88-45E9-96D9-6B439CD73A0AQ40283684-05A2CC11-D956-491B-AE6E-EBFC1F5A67DAQ40916503-39EA38D3-1175-4257-8160-C8F91E32597BQ42714930-5777BA86-FD33-4351-89E2-53504590A88FQ45711274-C6498FC8-5397-4569-BD76-B1C0572CC1D4Q47899192-F873E6E5-F649-4A78-B437-E03B07F8DCC0Q51742563-4875D551-A2D7-42BD-AF00-19B65887CF5AQ51902121-F69EC525-629A-45DE-91AC-D8391585E2D0Q51958182-6AB5261C-1E6E-4BE8-A168-34EE6DCBA283Q51969584-33996442-C889-4D16-BED1-03B5A7F12A7FQ51988901-BB96A107-92E3-4B10-9E8E-D03A94A20ED1Q53215966-83F970A8-B6CD-45B5-A703-22BC8D7F1A62Q53230322-DD5A0A34-093D-4720-831A-F6721E4FF3A1Q53323913-78921248-4330-4B29-A008-31598750EEF5Q53380063-368D8852-F2D9-4571-BF50-8C7A78B360BD
P2860
Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Gene dose of the epsilon 4 all ...... ate-onset Alzheimer's disease.
@en
Gene dose of the epsilon 4 all ...... ate-onset Alzheimer's disease.
@nl
type
label
Gene dose of the epsilon 4 all ...... ate-onset Alzheimer's disease.
@en
Gene dose of the epsilon 4 all ...... ate-onset Alzheimer's disease.
@nl
prefLabel
Gene dose of the epsilon 4 all ...... ate-onset Alzheimer's disease.
@en
Gene dose of the epsilon 4 all ...... ate-onset Alzheimer's disease.
@nl
P2860
P50
P356
P1433
P1476
Gene dose of the epsilon 4 all ...... late-onset Alzheimer's disease
@en
P2093
Bianchetti A
Trabucchi M
P2860
P304
P356
10.1002/ANA.410370509
P577
1995-05-01T00:00:00Z